Skip to main content

Giving Oncology Teams a Clearer View of Patient Symptoms

Blüm Health is supporting the development of Symbot, an AI voice chatbot platform designed to capture patient-reported symptoms more consistently, reduce the burden on clinicians and enable earlier, more informed intervention in oncology care.

Symbot: AI voice chatbot platform for oncology symptom assessment

Innovation project | AI voice technology | Oncology care | Patient-reported outcome measures | MVP development

Blüm Health has supported the development of Symbot in collaboration with The Clatterbridge Cancer Centre NHS Foundation Trust and Pfizer Ltd, an AI voice chatbot patient symptom platform designed to help improve the collection of symptom and side-effect data from oncology patients.

Clinicians are recommended to complete symptom checks and patient-reported outcome measures with oncology patients using the Common Terminology Criteria for Adverse Events. However, in routine clinical practice, it is rarely feasible to cover the full list of 88 measures in every consultation. This can mean that important insights into how treatment is affecting patients may be missed, particularly over the longer term when patients are discharged from secondary care.

Symbot aims to address this challenge by using conversational AI voice technology to support more comprehensive, consistent and efficient symptom assessment. The platform is being developed to help collect patient-reported symptom data in a structured way, while creating a more human-like and accessible experience for patients.

The project focused on developing a minimum viable product for user acceptability testing with clinicians, patients and the NHS ecosystem. The MVP will be deployed in a pilot and testing environment within The Clatterbridge Cancer Centre NHS Foundation Trust to assess the opportunity within a chosen oncology pathway.

By using an AI voice chatbot to support symptom assessment, Symbot has the potential to save clinician time, uncover symptoms that may not typically be detected, and capture patient inputs in a more standardised format. In the longer term, structured symptom data could support integration with Electronic Patient Records, enable more individualised care and provide valuable insights into the efficacy and impact of treatments.

For oncology patients, the project aims to support more thorough and consistent levels of care by identifying symptoms that might otherwise go unnoticed and creating opportunities for earlier intervention. For clinicians and care teams, Symbot is designed to support more efficient data collection, free up more patient-facing time and enable better insight into patients’ experience of treatment.

The project will also explore the commercialisation potential of the Symbot model, including a feature roadmap and launch plan for future development.

Relevant capabilities

  • AI-enabled healthcare product development

  • Voice chatbot and conversational interface design

  • Oncology pathway innovation

  • Patient-reported outcome measure collection

  • Structured symptom data capture

  • MVP development and pilot deployment

  • User acceptability testing with patients and clinicians

  • Clinical workflow support

  • Digital tools for treatment monitoring

  • Product roadmap and commercialisation planning

You can read more about the project here